risk stratification Inflammatory Gene Expression Score IDs High-Risk AML Patients Premium Unique inflammation-associated gene expression signatures in adult and pediatric AML patients may speed risk stratification and treatment decisions. Palmetto Finalizes Positive LCD for Prostate Cancer Risk Tests Tests like MDxHealth's SelectMDx, Bio-Techne's ExoDx Prostate, and various PSA scoring algorithms would be reimbursed if they pass a technical assessment. Polygenic Transcriptome Risk Scores for COPD Show Improved Cross-Ancestry Portability Researchers found that polygenic transcriptome risk scores worked better across ethnicities than polygenic risk scores to predict chronic obstructive pulmonary disease risk. Arcensus Hopes DTC Testing Will Help Genome Sequencing Become First-Line Rare Disease Diagnostic Premium Founded by ex-Centogene CEO Arndt Rolfs, the German startup is targeting the US and Middle East for its cardiology and cancer genetic risk reports. Researchers ID Genomic Signature to Risk Stratify Patients With Precancerous Breast Lesions In the study, presented at SABCS, researchers developed an 812-gene signature that could identify which patients with ductal carcinoma in situ need aggressive treatment. Oct 27, 2021 Polygenic Risk Scores Edge Toward Clinic, Though Disease Prediction Utility Questions Linger Premium Sep 28, 2021 Genetic Technologies, WashU Team up to Study Breast Cancer Risk in Woman of African Descent Sep 16, 2021 Polygenic Risk Scores for Breast, Prostate Cancer Adaptable for Cross-Ancestry Use, Study Shows Aug 27, 2021 Oncocyte Launches Prospective Registry to Drive DetermaRx Adoption, Improve Coverage Premium Jul 28, 2021 Sequencing Firm Phosphorus Tests Limits of Comprehensive Consumer Genomics With GeneCompass Premium Jul 22, 2021 Volpara Adding Invitae Genetic Test Ordering to Breast Risk Software Platform Jul 15, 2021 Glaucoma Polygenic Risk Score Appears Similarly Informative to Monogenic Risk Assessment Jun 30, 2021 Recuro Health Enters Genomics Market With MyLegacy Purchase from Cleveland Clinic Premium Jun 7, 2021 Lynparza Benefit in Early BRCA-Mutated Breast Cancer Reignites Universal Genetic Testing Discussion Premium Jan 26, 2021 BC Platforms, Finnish Researchers, Japan's Riken Partner on COVID-19 Risk Assessment Oct 26, 2020 GoodCell Raises $17.9M for Analytics Technology, Personal Biobanking Sep 9, 2020 Machine Learning Tool Enables Analysis of Complex, Polygenic Phenotypes With Epistastic Interactions Premium Aug 13, 2020 Weill Cornell Using $1.5M NIH Grant to Predict Severity of COVID-19 Cases Premium Jul 1, 2020 NIH Allocates $75M to Create eMERGE Risk Assessment Network Jun 18, 2020 After DNA-10K, NorthShore Looks to Expand Genomics Integration Into Primary Care Premium Jun 11, 2020 Diversity Problem Hinders Adoption of Polygenic Risk Scores, According to ESHG Panel May 13, 2020 The DNA Company Rebrands as My Next Health Following Acquisition May 7, 2020 Informatics Startup Breakthrough Genomics Developing Coronavirus Susceptibility Assessment Premium Apr 3, 2020 Adventist Health, CancerIQ Collaboration Identifying More Patients for Guidelines-Supported Genetic Testing Premium Jan 16, 2020 DNAFeed Adds Genetic Counseling to Scripps Polygenic Risk Study Premium Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.